COMMUNIQUÉS West-GlobeNewswire
-
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
24/04/2024 - 16:00 -
Immunocore announces upcoming presentation and posters at ASCO 2024
24/04/2024 - 16:00 -
ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences
24/04/2024 - 16:00 -
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 - 16:01 -
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 - 16:02 -
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 - 16:05 -
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
24/04/2024 - 16:05 -
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
24/04/2024 - 16:05 -
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
24/04/2024 - 16:09 -
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 - 16:15 -
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
24/04/2024 - 16:18 -
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
24/04/2024 - 13:00 -
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
24/04/2024 - 13:00 -
Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products
24/04/2024 - 13:00 -
Sharecare to report first quarter fiscal 2024 financial results on Thursday, May 9
24/04/2024 - 13:00 -
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
24/04/2024 - 13:00 -
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
24/04/2024 - 13:00 -
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
24/04/2024 - 13:00 -
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
24/04/2024 - 13:00
Pages